CGTXNasdaq United States
Market cap
$96.658 M
$1.08 -4.42%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
-$23.5M
Loss-making
Shares outstanding
95,093,746
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Cognition Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.